You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

Back to profitable growth

Since our listing in 2017, Arjo has had a strong and consistent focus on profitable growth – allowing us become a stronger company than we were three years ago. Through a number of initiatives, including increased operational agility and a strengthened commercial focus, we have successfully reached our first basecamp on our journey towards becoming the most trusted partner in driving healthier outcomes for people facing mobility challenges.

We have strengthened our position in the market across geographies

• Successful turnaround of the US market, +5,9% net sales growth (CAGR) since listing
• Established own sales companies in select markets
• Rebuild of distributor market allows substantial growth onwards
• While developing acute care, investments to strengthen long-term care – still great potential
• Service business growth, with significant remaining potential

Arjo.Marouane_555_555.jpg

We have streamlined our business – continuously improving profitability

• Improved operational leverage
• Continued improvements and restructuring of Rental business to enable margin development from 2020 onwards
• Good track record on realizing structural measures, still with remaining potential
• Continuous OPEX management allowing flexibility, while continuing to decline OPEX in relation to net sales

The organic agenda has been supported by acquisitions and partnerships

Acquisitions and partnerships

• ReNu Medical
• Atlas LiftTech
• Next Step Dynamics
• BrainLit
• Bruin Biometrics (BBI)
• AirPal

Our M&A perspective will be two-fold

• New opportunities to complement current portfolios
• Generate positive sales synergies

Divestments to optimize portfolio

• Acare
• Current focus on driving strong execution of recent acquisitions and partnerships